Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 973 to 978 of 978 entries
Sorted by: Best Match Show Resources per page
Quantifying Asymmetry in Gait: The Weighted Universal Symmetry Index to Evaluate 3D Ground Reaction Forces.

Frontiers in bioengineering and biotechnology

Alves SA, Ehrig RM, Raffalt PC, Bender A, Duda GN, Agres AN.
PMID: 33195140
Front Bioeng Biotechnol. 2020 Oct 23;8:579511. doi: 10.3389/fbioe.2020.579511. eCollection 2020.

Though gait asymmetry is used as a metric of functional recovery in clinical rehabilitation, there is no consensus on an ideal method for its evaluation. Various methods have been proposed to analyze single bilateral signals but are limited in...

Cite
Alves SA, Ehrig RM, Raffalt PC, et al. Quantifying Asymmetry in Gait: The Weighted Universal Symmetry Index to Evaluate 3D Ground Reaction Forces. Front Bioeng Biotechnol. 2020;8:579511doi: 10.3389/fbioe.2020.579511.
Alves, S. A., Ehrig, R. M., Raffalt, P. C., Bender, A., Duda, G. N., & Agres, A. N. (2020). Quantifying Asymmetry in Gait: The Weighted Universal Symmetry Index to Evaluate 3D Ground Reaction Forces. Frontiers in bioengineering and biotechnology, 8579511. https://doi.org/10.3389/fbioe.2020.579511
Alves, Sónia A, et al. "Quantifying Asymmetry in Gait: The Weighted Universal Symmetry Index to Evaluate 3D Ground Reaction Forces." Frontiers in bioengineering and biotechnology vol. 8 (2020): 579511. doi: https://doi.org/10.3389/fbioe.2020.579511
Alves SA, Ehrig RM, Raffalt PC, Bender A, Duda GN, Agres AN. Quantifying Asymmetry in Gait: The Weighted Universal Symmetry Index to Evaluate 3D Ground Reaction Forces. Front Bioeng Biotechnol. 2020 Oct 23;8:579511. doi: 10.3389/fbioe.2020.579511. eCollection 2020. PMID: 33195140; PMCID: PMC7644861.
Copy Download .nbib Format: NLM
Patient controlled analgesia for the management of acute pain in the emergency department: A systematic review.

The American journal of emergency medicine

Papa L, Maguire L, Bender M, Boyd M, Patel S, Samcam I.
PMID: 34775197
Am J Emerg Med. 2022 Jan;51:228-238. doi: 10.1016/j.ajem.2021.10.042. Epub 2021 Nov 06.

BACKGROUND: The most common presenting complaint to the emergency department (ED) is pain. Several studies have shown that a large proportion of ED patients either receive no or sub-optimal analgesia. Patient-controlled analgesia (PCA) pumps used in the post-operative setting...

Cite
Papa L, Maguire L, Bender M, et al. Patient controlled analgesia for the management of acute pain in the emergency department: A systematic review. Am J Emerg Med. 2021;51:228-238doi: 10.1016/j.ajem.2021.10.042.
Papa, L., Maguire, L., Bender, M., Boyd, M., Patel, S., & Samcam, I. (2022). Patient controlled analgesia for the management of acute pain in the emergency department: A systematic review. The American journal of emergency medicine, 51228-238. https://doi.org/10.1016/j.ajem.2021.10.042
Papa, Linda, et al. "Patient controlled analgesia for the management of acute pain in the emergency department: A systematic review." The American journal of emergency medicine vol. 51 (2022): 228-238. doi: https://doi.org/10.1016/j.ajem.2021.10.042
Papa L, Maguire L, Bender M, Boyd M, Patel S, Samcam I. Patient controlled analgesia for the management of acute pain in the emergency department: A systematic review. Am J Emerg Med. 2022 Jan;51:228-238. doi: 10.1016/j.ajem.2021.10.042. Epub 2021 Nov 06. PMID: 34775197.
Copy Download .nbib Format: NLM
On the learning of addictive behavior: Sensation-seeking propensity predicts dopamine turnover in dorsal striatum.

Brain imaging and behavior

Chang NHS, Kumakura Y, Møller A, Linnet J, Bender D, Doudet DJ, Vafaee MS, Gjedde A.
PMID: 34417966
Brain Imaging Behav. 2021 Aug 21; doi: 10.1007/s11682-021-00509-5. Epub 2021 Aug 21.

We asked if sensation-seeking is linked to premorbid personality characteristics in patients with addictive disorders, or the characteristics follow the sensation-seeking activity. We interpreted the former as a state associated with normal rates of dopamine synthesis, and the latter...

Cite
Chang NHS, Kumakura Y, Møller A, et al. On the learning of addictive behavior: Sensation-seeking propensity predicts dopamine turnover in dorsal striatum. Brain Imaging Behav. 2021;doi: 10.1007/s11682-021-00509-5.
Chang, N. H. S., Kumakura, Y., Møller, A., Linnet, J., Bender, D., Doudet, D. J., Vafaee, M. S., & Gjedde, A. (2021). On the learning of addictive behavior: Sensation-seeking propensity predicts dopamine turnover in dorsal striatum. Brain imaging and behavior, . https://doi.org/10.1007/s11682-021-00509-5
Chang, Natalie Hong Siu, et al. "On the learning of addictive behavior: Sensation-seeking propensity predicts dopamine turnover in dorsal striatum." Brain imaging and behavior vol. (2021). doi: https://doi.org/10.1007/s11682-021-00509-5
Chang NHS, Kumakura Y, Møller A, Linnet J, Bender D, Doudet DJ, Vafaee MS, Gjedde A. On the learning of addictive behavior: Sensation-seeking propensity predicts dopamine turnover in dorsal striatum. Brain Imaging Behav. 2021 Aug 21; doi: 10.1007/s11682-021-00509-5. Epub 2021 Aug 21. PMID: 34417966.
Copy Download .nbib Format: NLM
An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters.

Frontiers in pharmacology

Dvorak V, Wiedmer T, Ingles-Prieto A, Altermatt P, Batoulis H, Bärenz F, Bender E, Digles D, Dürrenberger F, Heitman LH, IJzerman AP, Kell DB, Kickinger S, Körzö D, Leippe P, Licher T, Manolova V, Rizzetto R, Sassone F, Scarabottolo L, Schlessinger A, Schneider V, Sijben HJ, Steck AL, Sundström H, Tremolada S, Wilhelm M, Wright Muelas M, Zindel D, Steppan CM, Superti-Furga G.
PMID: 34447313
Front Pharmacol. 2021 Aug 10;12:722889. doi: 10.3389/fphar.2021.722889. eCollection 2021.

The solute carrier (SLC) superfamily represents the biggest family of transporters with important roles in health and disease. Despite being attractive and druggable targets, the majority of SLCs remains understudied. One major hurdle in research on SLCs is the...

Cite
Dvorak V, Wiedmer T, Ingles-Prieto A, et al. An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters. Front Pharmacol. 2021;12:722889doi: 10.3389/fphar.2021.722889.
Dvorak, V., Wiedmer, T., Ingles-Prieto, A., Altermatt, P., Batoulis, H., Bärenz, F., Bender, E., Digles, D., Dürrenberger, F., Heitman, L. H., IJzerman, A. P., Kell, D. B., Kickinger, S., Körzö, D., Leippe, P., Licher, T., Manolova, V., Rizzetto, R., Sassone, F., Scarabottolo, L., Schlessinger, A., Schneider, V., Sijben, H. J., Steck, A. L., Sundström, H., Tremolada, S., Wilhelm, M., Wright Muelas, M., Zindel, D., Steppan, C. M., & Superti-Furga, G. (2021). An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters. Frontiers in pharmacology, 12722889. https://doi.org/10.3389/fphar.2021.722889
Dvorak, Vojtech, et al. "An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters." Frontiers in pharmacology vol. 12 (2021): 722889. doi: https://doi.org/10.3389/fphar.2021.722889
Dvorak V, Wiedmer T, Ingles-Prieto A, Altermatt P, Batoulis H, Bärenz F, Bender E, Digles D, Dürrenberger F, Heitman LH, IJzerman AP, Kell DB, Kickinger S, Körzö D, Leippe P, Licher T, Manolova V, Rizzetto R, Sassone F, Scarabottolo L, Schlessinger A, Schneider V, Sijben HJ, Steck AL, Sundström H, Tremolada S, Wilhelm M, Wright Muelas M, Zindel D, Steppan CM, Superti-Furga G. An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters. Front Pharmacol. 2021 Aug 10;12:722889. doi: 10.3389/fphar.2021.722889. eCollection 2021. PMID: 34447313; PMCID: PMC8383457.
Copy Download .nbib Format: NLM
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets.

NPJ vaccines

Marsh GA, McAuley AJ, Au GG, Riddell S, Layton D, Singanallur NB, Layton R, Payne J, Durr PA, Bender H, Barr JA, Bingham J, Boyd V, Brown S, Bruce MP, Burkett K, Eastwood T, Edwards S, Gough T, Halpin K, Harper J, Holmes C, Horman WSJ, van Vuren PJ, Lowther S, Maynard K, McAuley KD, Neave MJ, Poole T, Rootes C, Rowe B, Soldani E, Stevens V, Stewart CR, Suen WW, Tachedjian M, Todd S, Trinidad L, Walter D, Watson N, Drew TW, Gilbert SC, Lambe T, Vasan SS.
PMID: 33972565
NPJ Vaccines. 2021 May 10;6(1):67. doi: 10.1038/s41541-021-00315-6.

Vaccines against SARS-CoV-2 are likely to be critical in the management of the ongoing pandemic. A number of candidates are in Phase III human clinical trials, including ChAdOx1 nCoV-19 (AZD1222), a replication-deficient chimpanzee adenovirus-vectored vaccine candidate. In preclinical trials,...

Cite
Marsh GA, McAuley AJ, Au GG, et al. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets. NPJ Vaccines. 2021;6(1):67doi: 10.1038/s41541-021-00315-6.
Marsh, G. A., McAuley, A. J., Au, G. G., Riddell, S., Layton, D., Singanallur, N. B., Layton, R., Payne, J., Durr, P. A., Bender, H., Barr, J. A., Bingham, J., Boyd, V., Brown, S., Bruce, M. P., Burkett, K., Eastwood, T., Edwards, S., Gough, T., Halpin, K., Harper, J., Holmes, C., Horman, W. S. J., van Vuren, P. J., Lowther, S., Maynard, K., McAuley, K. D., Neave, M. J., Poole, T., Rootes, C., Rowe, B., Soldani, E., Stevens, V., Stewart, C. R., Suen, W. W., Tachedjian, M., Todd, S., Trinidad, L., Walter, D., Watson, N., Drew, T. W., Gilbert, S. C., Lambe, T., & Vasan, S. S. (2021). ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets. NPJ vaccines, 6(1), 67. https://doi.org/10.1038/s41541-021-00315-6
Marsh, Glenn A, et al. "ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets." NPJ vaccines vol. 6,1 (2021): 67. doi: https://doi.org/10.1038/s41541-021-00315-6
Marsh GA, McAuley AJ, Au GG, Riddell S, Layton D, Singanallur NB, Layton R, Payne J, Durr PA, Bender H, Barr JA, Bingham J, Boyd V, Brown S, Bruce MP, Burkett K, Eastwood T, Edwards S, Gough T, Halpin K, Harper J, Holmes C, Horman WSJ, van Vuren PJ, Lowther S, Maynard K, McAuley KD, Neave MJ, Poole T, Rootes C, Rowe B, Soldani E, Stevens V, Stewart CR, Suen WW, Tachedjian M, Todd S, Trinidad L, Walter D, Watson N, Drew TW, Gilbert SC, Lambe T, Vasan SS. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets. NPJ Vaccines. 2021 May 10;6(1):67. doi: 10.1038/s41541-021-00315-6. PMID: 33972565; PMCID: PMC8110954.
Copy Download .nbib Format: NLM
Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown.

Frontiers in pediatrics

Rasmussen MI, Hansen ML, Pichler G, Dempsey E, Pellicer A, El-Khuffash A, A S, Piris-Borregas S, Alsina M, Cetinkaya M, Chalak L, Özkan H, Baserga M, Sirc J, Fuchs H, Ergenekon E, Arruza L, Mathur A, Stocker M, Otero Vaccarello O, Szczapa T, Sarafidis K, Królak-Olejnik B, Memisoglu A, Reigstad H, Rafińska-Ważny E, Hatzidaki E, Peng Z, Gkentzi D, Viellevoye R, De Buyst J, Mastretta E, Wang P, Hahn GH, Bender L, Cornette L, Tkaczyk J, Del Rio R, Fumagalli M, Papathoma E, Wilinska M, Naulaers G, Sadowska-Krawczenko I, Lecart C, Couce ML, Fredly S, Heuchan AM, Karen T, Greisen G.
PMID: 34322460
Front Pediatr. 2021 Jul 12;9:647880. doi: 10.3389/fped.2021.647880. eCollection 2021.

No abstract available.

Cite
Rasmussen MI, Hansen ML, Pichler G, et al. Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown. Front Pediatr. 2021;9:647880doi: 10.3389/fped.2021.647880.
Rasmussen, M. I., Hansen, M. L., Pichler, G., Dempsey, E., Pellicer, A., El-Khuffash, A., A, S., Piris-Borregas, S., Alsina, M., Cetinkaya, M., Chalak, L., Özkan, H., Baserga, M., Sirc, J., Fuchs, H., Ergenekon, E., Arruza, L., Mathur, A., Stocker, M., Otero Vaccarello, O., Szczapa, T., Sarafidis, K., Królak-Olejnik, B., Memisoglu, A., Reigstad, H., Rafińska-Ważny, E., Hatzidaki, E., Peng, Z., Gkentzi, D., Viellevoye, R., De Buyst, J., Mastretta, E., Wang, P., Hahn, G. H., Bender, L., Cornette, L., Tkaczyk, J., Del Rio, R., Fumagalli, M., Papathoma, E., Wilinska, M., Naulaers, G., Sadowska-Krawczenko, I., Lecart, C., Couce, M. L., Fredly, S., Heuchan, A. M., Karen, T., & Greisen, G. (2021). Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown. Frontiers in pediatrics, 9647880. https://doi.org/10.3389/fped.2021.647880
Rasmussen, Marie Isabel, et al. "Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown." Frontiers in pediatrics vol. 9 (2021): 647880. doi: https://doi.org/10.3389/fped.2021.647880
Rasmussen MI, Hansen ML, Pichler G, Dempsey E, Pellicer A, El-Khuffash A, A S, Piris-Borregas S, Alsina M, Cetinkaya M, Chalak L, Özkan H, Baserga M, Sirc J, Fuchs H, Ergenekon E, Arruza L, Mathur A, Stocker M, Otero Vaccarello O, Szczapa T, Sarafidis K, Królak-Olejnik B, Memisoglu A, Reigstad H, Rafińska-Ważny E, Hatzidaki E, Peng Z, Gkentzi D, Viellevoye R, De Buyst J, Mastretta E, Wang P, Hahn GH, Bender L, Cornette L, Tkaczyk J, Del Rio R, Fumagalli M, Papathoma E, Wilinska M, Naulaers G, Sadowska-Krawczenko I, Lecart C, Couce ML, Fredly S, Heuchan AM, Karen T, Greisen G. Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown. Front Pediatr. 2021 Jul 12;9:647880. doi: 10.3389/fped.2021.647880. eCollection 2021. PMID: 34322460; PMCID: PMC8310995.
Copy Download .nbib Format: NLM
Showing 973 to 978 of 978 entries